Suchergebnisse - "Silversides, Jonathan A"

PubPharm (39)

1

Fluid management and active fluid removal practices: a global survey of paediatric critical care physicians

enthalten in: Intensive Care Medicine – Paediatric and Neonatal | 2024

von Aramburo, A. | Raman, S. | Silversides, J. | +3

2

Vascular leak in sepsis : physiological basis and potential therapeutic advances

enthalten in: Critical care (London, England) | 2024

von McMullan, R. | McAuley, D. | O'Kane, C. | +1

3

Vascular leak in sepsis: physiological basis and potential therapeutic advances

enthalten in: Critical care | 2024

von McMullan, R. | McAuley, D. | O’Kane, C. | +1

4

Correction : Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation Correction: After Resuscitation-2 (RADAR-2) randomised clinical trial

enthalten in: Intensive care medicine | 2023

von Silversides, J. | McMullan, R. | Emerson, L. | +11

ErratumFor: Intensive Care Med. 2022 Feb;48(2):190-200. - PMID 34913089

5

Fluid Therapy in Sepsis : Does It Matter How Much?

enthalten in: Chest | 2023

von Silversides, J. | Rochwerg, B.

CommentOn: Chest. 2023 Oct;164(4):892-912. - PMID 37142091

6

Correction: Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation Correction: After Resuscitation-2 (RADAR-2) randomised clinical trial

enthalten in: Intensive care medicine | 2023

von Silversides, J. | McMullan, R. | Emerson, L. | +11

7

Physiology Is Vital to Precision Medicine in Acute Respiratory Distress Syndrome and Sepsis

enthalten in: American journal of respiratory and critical care medicine | 2022

von Goligher, E. | Telias, I. | Sahetya, S. | +9

CommentIn: Am J Respir Crit Care Med. 2022 Jul 1;206(1):121-122. - PMID 35533404

8

Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness : the Role of Active Deresuscitation After Resuscitation-2 (RADAR-2) randomised clinical trial

enthalten in: Intensive care medicine | 2022

von Silversides, J. | McMullan, R. | Emerson, L. | +11

ErratumIn: Intensive Care Med. 2023 Nov;49(11):1440. - PMID 37642672

9

Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation After Resuscitation-2 (RADAR-2) randomised clinical trial

enthalten in: Intensive care medicine | 2021

von Silversides, J. | McMullan, R. | Emerson, L. | +11

10

Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation After Resuscitation-2 (RADAR-2) randomised clinical trial

enthalten in: Intensive care medicine | 2021

von Silversides, J. | McMullan, R. | Emerson, L. | +11